| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1346-8138.2009.00777.X |
| P698 | PubMed publication ID | 20175849 |
| P2093 | author name string | Nawaf Al-Mutairi | |
| Shahat Al-Farag | |||
| Ahmed Al-Mutairi | |||
| Mazen Al-Shiltawy | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Middle East | Q7204 |
| comorbidity | Q1414874 | ||
| P304 | page(s) | 146-155 | |
| P577 | publication date | 2010-02-01 | |
| P1433 | published in | The Journal of Dermatology | Q18225322 |
| P1476 | title | Comorbidities associated with psoriasis: an experience from the Middle East | |
| P478 | volume | 37 |
| Q34156420 | A practical approach to monitoring patients on biological agents for the treatment of psoriasis |
| Q89970104 | A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates |
| Q60683249 | Abordaje integral de la comorbilidad del paciente con psoriasis |
| Q38935290 | Adipokines in psoriasis: An important link between skin inflammation and metabolic alterations. |
| Q38673766 | An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies |
| Q88979554 | Assessment of subclinical cardiac damage in chronic plaque psoriasis patients: a case control study |
| Q92109846 | Assessment of the Possible Role of FOXP3 Gene (rs3761548) Polymorphism in Psoriasis Vulgaris Susceptibility and Pathogenesis: Egyptian Study |
| Q26772143 | Association between Psoriasis and Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis |
| Q30252078 | Association between psoriasis and chronic obstructive pulmonary disease: A systematic review and meta-analysis |
| Q37416297 | Can pregnancy-associated plasma protein-A be a marker for the assessment of atherosclerosis risk in patients with chronic plaque psoriasis? |
| Q34812877 | Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review |
| Q38058361 | Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. |
| Q38429390 | Co-morbidities in psoriasis: a hospital-based case-control study |
| Q40311189 | Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry. |
| Q35212941 | Do eating disorders accompany metabolic syndrome in psoriasis patients? Results of a preliminary study |
| Q38098647 | Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. |
| Q38203516 | Exhaled nitric oxide as a biomarker in COPD and related comorbidities |
| Q38838470 | Experience and challenges for biologic use in the treatment of moderate-to-severe psoriasis in Africa and the Middle East region. |
| Q92818972 | From randomized clinical trials to real life data. An Italian clinical experience with ixekizumab and its management |
| Q55347185 | Gene polymorphisms of TNF-238G/A, TNF-308G/A, IL10-1082G/A, TNFAIP3, and MC4R and comorbidity occurrence in a Romanian population with psoriasis. |
| Q91650838 | Gut microbiota and nutrient interactions with skin in psoriasis: A comprehensive review of animal and human studies |
| Q40988865 | High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study |
| Q33878257 | Incidence of Pulmonary Arterial Hypertension in Patients with Psoriasis: A Retrospective Cohort Study. |
| Q37961072 | Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement |
| Q93362774 | Metabolic syndrome and psoriatic arthritis among patients with psoriasis vulgaris: Quality of life and prevalence |
| Q39493546 | Prevalence and comorbidities in adults with psoriasis compared to atopic eczema |
| Q35753936 | Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom |
| Q46180528 | Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment |
| Q35045850 | Psoriasis and Metabolic Syndrome--scientific evidence and therapeutic implications |
| Q57585034 | Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy |
| Q38629361 | Psoriasis and Smoking: A Systematic Literature Review and Meta-Analysis With Qualitative Analysis of Effect of Smoking on Psoriasis Severity. |
| Q89885278 | Psoriasis and cardiovascular disorders: association or epiphenomenon? Meta-analysis of observational studies |
| Q34418506 | Psoriasis and comorbidities: links and risks |
| Q35263254 | Psoriasis and dyslipidemia |
| Q35262970 | Psoriasis and high blood pressure |
| Q38151781 | Psoriasis and smoking: a systematic review and meta-analysis |
| Q34643790 | Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis |
| Q64073187 | Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls |
| Q34356844 | Psoriasis, cardiovascular events, cancer risk and alcohol use: evidence-based recommendations based on systematic review and expert opinion. |
| Q26765175 | Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background |
| Q38114903 | Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis |
| Q28073922 | Psoriasis: new comorbidities |
| Q36741063 | Rapid improvement of palmoplantar psoriasis after cessation of smoking. |
| Q50353072 | Risk of sudden sensorineural hearing loss in patients with psoriasis: a retrospective cohort study |
| Q37903373 | Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms |
| Q46818451 | Social problem-solving, perceived stress, negative life events, depression and life satisfaction in psoriasis |
| Q34439924 | Targeted phototherapy using 308 nm Xecl monochromatic excimer laser for psoriasis at difficult to treat sites |
| Q47731062 | The Prevalence of Anxiety and Depression in Arab Dermatology Patients |
| Q99566147 | The Unmet Need for Clinical Guidelines on the Management of Patients with Plaque Psoriasis in Africa and the Middle East |
| Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
| Q38064779 | The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies |
| Q39158398 | The effect of tumour necrosis factor inhibitor therapy on the incidence of myocardial infarction in patients with psoriasis: A retrospective study |
| Q47177526 | The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial |
| Q55312824 | Young patients with risk factors prevalent in the elderly – differences in comorbidity depending on severity of psoriasis: a nationwide cross-sectional study in Swedish health registers. |
Search more.